Physician profile
Farhad Safi
NPI 1477759454
$4,614.50
in general payments reported to CMS, 2019-2025
16 companies · $853 in 2025
The $853 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $62.17 · 2021: $277 · 2022: $531 · 2023: $1,679 · 2024: $891 · 2025: $853.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,423.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,423.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $816.28 | 2021-2024 | Iluvien, Yutiq |
| Genentech USA, INC. | $749.61 | 2022-2025 | Vabysmo |
| Alcon Vision LLC | $742.57 | 2019-2025 | Ngenuity, Constellation, Unity |
| Regeneron Healthcare Solutions, INC. | $733.67 | 2022-2025 | Eylea Hd, Eylea |
| Apellis Pharmaceuticals, INC. | $466.80 | 2022-2025 | Syfovre |
| Astellas Pharma US INC | $390.87 | 2023-2025 | Izervay |
| Abbvie INC. | $284.36 | 2022-2025 | Ozurdex |
| Novartis Pharmaceuticals Corporation | $125.00 | 2019 | |
| Coherus Oncology, INC. | $64.55 | 2022-2023 | |
| Allergan, INC. | $62.17 | 2020 | |
| Staar Surgical Company | $56.00 | 2019 | |
| Sight Sciences, INC. | $49.94 | 2025 | Omni Surgical System |
| Ani Pharmaceuticals, INC. | $21.97 | 2025 | Purified Cortrophin Gel |
| Biotissue Holdings INC. | $19.72 | 2024 | |
| Harrow Eye, LLC | $15.96 | 2025 | Iheezo |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $15.03 | 2025 | Xipere |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farhad Safi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.